Pasteurized Autograft-Prosthesis Composite Reconstruction May Not Be a Viable Primary Procedure for Large Skeletal Defects after Resection of Sarcoma

Table 1

Patients demographics .

Characteristics	Number of patients (%)
Age
≤14, >40	50 (35.2)
15–40	92 (64.8)
Average 24 years (4–72)
Gender
Male	90 (63.3)
Female	52 (36.7)
Pathologic diagnosis
Osteosarcoma	112 (78.9)
Chondrosarcoma	15 (10.6)
Ewing’s sarcoma	5 (3.5)
Metastatic carcinoma	3 (2.1)
MFH, bone	2 (1.4)
	5 (3.5)
Initial tumor volume (cc)
≤200 ml	100 (70.4)
>200 ml	42 (29.6)
Average	186.2
Location
Femur
Proximal	26 (18.3)
Distal	44 (30.9)
Total	6 (4.2)
Pelvis	15 (10.6)
Humerus
Proximal	10 (7.1)
Total	2 (1.4)
Tibia
Proximal	39 (27.5)
Pasteurization length (cm)
≤10 cm	36 (25.4)
>10 cm	106 (74.6)
Fixation modality
Cemented	127 (89.4)
Cementless	15 (10.6)
Local recurrence
Proximal femur	5 (3.5)
Distal femur	3 (2.1)
Proximal tibia	4 (2.8)
Metastasis	51 (36)
Final status
Continuous disease-free	86 (60.6)
No evidence of disease	15 (10.6)
Died of disease	39 (27.4)
Alive with disease	2 (1.4)
Follow-up
Average 110 months (21–278)

Each case of giant cell tumor, rhabdomyosarcoma, synovial sarcoma, hemangioendothelioma, and desmoplastic fibroma.